Shares in the world’s largest pure-play med-tech firm hit $41.57 – a 52-week high – on their way to a $41.45 close on Wall Street yesterday afternoon, ending the trading day up 1.5%. Since August 22, 2011, MDT shares have gained 32.5%.
Medtronic in May posted a 28% profit surge during its fiscal 4th quarter profits, beating Wall Street’s expectations by a penny on sales growth of 4.4%.
Analysts on The Street are expecting Medtronic to post adjusted earnings per share of 85¢.
Special attention will be paid today to Medtronic’s bread-and-butter cardiac rhythm management numbers, seen as a bellwether for the CRM market as a whole, and to its spine business. Both sectors have slumped since the economic downturn began as the oughts wound down.
On June 4-5, DeviceTalks is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring, bringing you the best and brightest minds in the industry.
Heidi Dohse: Sr. Program Manager, Healthcare, Google, Founder, Tour de Heart Foundation, Acessa Health Inc. Michael J. Pederson: Senior Vice President, Cardiac Arrhythmias and Heart Failure Division, Abbott Hon. Melvin Carter: Mayor, Saint Paul Tim Philips: Compliance Officer, FDA’s Office of Medical Device and Radiological Health Operations Dr. Myriam J. Curet, MD, FACS: Chief Medical Officer, Intuitive Surgical
Take a look at our incredible line up of speakers and join us now.
Use the code "KEYNOTE" to save 15% on the cost of registration.